P3 Health Partners Inc. reported $1.50B of revenue over the trailing twelve months, +2.8% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.50B (to Q2 2026). Net income: −$98M, trailing twelve months to Q2 2026. Operating margin: −10.0%, trailing twelve months to Q2 2026. EPS: −$33.06, trailing twelve months to Q2 2026.

PIIIP3 Health Partners Inc.

Healthcare

$5.24-36% 1Y

$5.24

$1.5252 weeks$16.47

PIII as reported

P3 Health Partners Inc. reported $1.50B of revenue over the trailing twelve months, +2.8% on the year before. 9 reported series are charted on this page, each one as filed.

$1.50B

Revenue, trailing twelve months · to Q2 2026 · +2.8% against the twelve months before

Net income: −$98M
Net income · −33% year on year · trailing twelve months to Q2 2026
Operating margin: −10.0%
Operating margin · trailing twelve months to Q2 2026
EPS: −$33.06
EPS · −34% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for PIII, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.50B	+2.8%	Q2 2026
Net income	−$98M	−33%	Q2 2026
EPS	−$33.06	−34%	Q2 2026
Operating margin	−10.0%	n/a	Q2 2026
Net margin	−6.6%	n/a	Q2 2026
ROE	188%	n/a	Q2 2026
ROA	−19%	n/a	Q2 2026
ROIC	−131%	n/a	Q2 2026
Free cash flow	−$110M	n/a	Q4 2024 · 6 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.